TRP.AX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 29, 2025
Report Source: 2025 2nd Quarter Report
Tissue Repair Ltd. Stock Analysis TRP.AX
Tissue Repair Ltd. is a clinical stage bio pharmaceutical company, which develops advanced wound healing products targeting applications in the chronic wound and aesthetic procedure aftercare markets, with the potential for further development of related technologies. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-11-18. The firm is focused in entering Phase III clinical trials in chronic wounds for its lead drug candidate Chronic wound treatment (TR-987), with a secondary focus on commercializing Post-procedure cosmeceutical (TR Pro+) a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its other applications of Glucoprime technology include the treatment of burns, an over the counter/pharmacy wound product, new bandage and scaffold products impregnated with Tissue Repair’s active pharmaceutical ingredient, veterinary products, among others.
Read More Tissue Repair Ltd (TRP.AX) Chart
Key Statistics of Tissue Repair Ltd (TRP.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.13Volume
17.25KP/E Ratio (TTM)
-52 Week Range
Market Cap
8.16MAvg. Volume
30.50KDividend Yield
-Financial Metrics & Statements of Tissue Repair Ltd (TRP.AX)
FAQ's for Tissue Repair Ltd (TRP.AX)
- According to Musaffa’s Shariah screening methodology, Tissue Repair Ltd (TRP.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.